DrugDashboards

Paroxetine Hydrochloride

paroxetine hydrochloride · PAROXETINE HYDROCHLORIDE 12.5 mg/1 · Tablet, Film Coated, Extended Release · Oral · Apotex Corp

NDC 60505-1316-03 · 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE · NDA AUTHORIZED GENERIC · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The generic price is up 13% over the past year, to $0.4918 per unit. The brand (Paxil Cr) runs $10.80 per unit 27× more. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.4918per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Federal ceiling (Big4)$0.1620per unitApotex Corporation · Jan 1, 202633% of what pharmacies pay — a deeper discount than 90% of drugs with this benchmark
  • Medicaid generic ceiling (FUL)$0.4918per TABweighted avg manufacturer price $0.1982 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 62175-0470-32) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of sale
$1.13per unit
middle half $0.8602$2.02 · 3,456 plans · Apr 1, 2026
Est. net of rebates
≈ $1.13
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
63%of plans cover it
tier 4 · prior auth 30% · step therapy 0% · qty limit 86%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

$0$1.00$2.00May 2020Sep 2026$0.4918
77 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$14.75
#90 count
$44.26

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$92,895
3,395 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 3 active manufacturers+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for paroxetine hydrochloride (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
NDA020936
TE code
AB
Approval date
Feb 16, 1999
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · TerminatedMar 24, 2014
    Apotex Inc.Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.
  • Class II · TerminatedMar 24, 2014
    Apotex Inc.Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.
  • Class II · TerminatedMar 24, 2014
    Apotex Inc.Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

Manufacturers of paroxetine hydrochloride (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
Apotex CorpPAROXETINE HYDROCHLORIDE 12.5 mg/1Jul 15, 2026Sep 3, 2026
Apotex CorpPAROXETINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Apotex CorpPAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Apotex CorpPAROXETINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Apotex CorpPAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackPAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Lannett Company, Inc.PAROXETINE HYDROCHLORIDE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Lannett Company, Inc.PAROXETINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Lannett Company, Inc.PAROXETINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Paroxetine Hydrochloride — NDC 60505-1316-03," retrieved September 3, 2026, https://drugdashboards.com/drug/60505131603.

Free to cite with attribution — see how the data is put together.